Is Prenetics Global Limited Warrant a good investment? Prenetics Global Limited Warrant (PRENW) is currently trading at 0.0130 USD.
Earnings Schedule: Prenetics Global Limited Warrant is expected to release its next earnings report on Sept. 11, 2026.
No, it does not currently pay a dividend.
Prenetics Global Limited Warrant is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Sept. 11, 2026. The company currently has a trailing EPS of -11.04.
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Community Discussion